Viewing data from:

MECLOFENAMATE SODIUM

ANDA

MECLOFENAMATE SODIUM | A071641 | WATSON LABORATORIES INC

1 strength0 unique patents0 unique exclusivities

API Supply Chain2 active DMFs5 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

WR GRACE AND COMECLOFENAMATE SODIUM USP

DMF 55841984

YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTDMECLOFENAMATE SODIUM

DMF 227952009

PROFARMACO SRLInactiveMECLOFENAMATE SODIUM

DMF 57411985

FINE CHEMICALS CORPInactiveMECLOFENAMATE SODIUM

DMF 62241986

CAMBREX PROFARMACO MILANO SRLInactiveMECLOFENAMATE SODIUM

DMF 68571987

QUIMICA SINTETICA SAInactiveMECLOFENAMATE SODIUM USP

DMF 68711987

WARNER LAMBERT COInactiveMECLOFENAMATE SODIUM

DMF 81441989

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 100MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Aug 11, 1987

No patent or exclusivity listings for this strength.